Assisted Reproductive Technology (ART) Market size was $22.31 billion for 2015 and is predicted to be evaluated at $31.41 billion by end of forecast period registering CAGR of 4.4%.
ART is a modern technique used to treat infertility. The procedures included in it are gamete intrafallopian transfer (GIFT), in vitro fertilization (IVF), zygote intrafallopian transfer (ZIFT) and intracytoplasmic sperm injection (ICSI). In vitro fertilization (IVF) is the leading method in which eggs and sperms are combined in laboratory and fertilized eggs are transferred into uterus of woman. IVF process includes stimulation of ovaries, egg recovery, fertilization, embryo culture and transfer of embryo.
GIFT (Gamete intrafallopian transfer)is a methodin which gametes are transferred into fallopian tube of woman and fertilization takes place in fallopian tubes. The method is performed only if fallopian tubes are functioning normally. In ZIFT (zygote intrafallopian transfer) fertilization occurs in laboratory instead of fallopian tube and fertilized eggs are moved to fallopian tube instead of uterus. ICSI (intracytoplasmic sperm injection) is a technique in which sperm is directly inserted into matured egg. In U.S ICSI methodis very popular and leads ART methods.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/506
The industry is segmented into fresh donor segment and frozen non-donor segment.
Fresh donor segment exceeded $1.3 billion revenue mark for 2015 and is predicted to register more than 5% CAGR during forecast timeframe. The proportion of donor eggs used in assisted reproductive technology cycles grows with age. As per CDC (Centers for Disease Control and Prevention), the kind of ART (assisted reproductive technology) cycles differ with woman’s age. These cycles where woman uses own eggs is mostly dominated by young women.For instance, 97.01% of women below 35 years of age used their own eggs for fertilization.
Frozen non-donor segment is predicted to register CAGR of 5.8% during forecast timeframe.
APAC assisted reproductive technology market share contributed more than 19% of total revenue and is predicted to register CAGR of 6.1% during forecast timeframe. Rapid growth in healthcare sector in nations like Japan, China and India is predicted to promote industry expansion during forecast period.
North America assisted reproductive technologymarketsize was evaluated at more than $9 billion for 2015 and is anticipated to be evaluated at greater than $11 billion by end of 2023. It is predicted to register CAGR of about 2.7% during forecast timeframe. Rise in infertility owing to fatness and demographical changes have fuelled expansion of North America assisted reproductive technology industry.
Europe assisted reproductive technology market contributed more than 22.51% of the total revenue share and is predicted to register a CAGR of 2.7% during forecast timeframe.
Read full market research report “Assisted Reproductive Technology (ART) Market Size by Procedure (Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, Egg/Embryo bank), Industry Analysis Report, Regional Outlook (U.S, Canada, UK, France, Germany, Italy, Spain, China, India, Japan, Brazil, Mexico, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023”, please click on the link below:
Key industry players profiled in the report include Vitro Life, Research Instruments,Thermo Fisher Scientific Incorporation, Irvine scientific, Genea Limited,Research Instruments, IVFtech ApS, Origio a/s, Esco Micro Private Limited, Cook Medicaland Smiths Medical.
Browse Related Reports:
- HIV Diagnostics Market Size By Product [Antibody Tests (HIV-1 Screening, ELISA/EIA, Home Access Dried Blood Spot, Rapid Test, HIV-1 Confirmatory Steps, Western Blot, Indirect Immunoflorescent Antibody Assay (IIFA), Line Immunoassay , RadioImmuno Precipitation Assay (RIPA), HIV-2 & Group O Test, Blood Antibody, Dried Blood Spot), Viral Identification Assay (p24 Antigen, Qualitative PCR, Viral Culture), CD4, Viral Load, Early Infant Diagnosis], Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Japan, China, South Africa, Brazil), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023
- Contraceptives Market Size By Product (Drugs [Oral Contraceptive Pills, Injectables, Topical], By Devices Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal Implants, Copper IUD, Hormonal IUD], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Japan, China, India, Brazil, South Africa), Application Potential, Price Trend, Competitive Market Share & Forecast, 2016 – 2023
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Company Name: Global Market Insights Inc.
Contact Person: Jack Davis
Address:29L Atlantic Avenu, Suite L 105
City: Ocean View
Country: United States